(Q58211548)

1

0 references

Efthimios Sivridis

2

0 references

Nikolaos E. Bechrakis

3

0 references

Gregor Willerding

4

0 references

Georgios St. Charitoudis

5

0 references

Michael H. Foerster

6

0 references

Kevin C. Gatter

7

0 references

Michael I. Koukourakis

Clinical & Experimental Metastasis

9

0 references

publication date

9 October 2011

0 references

published in

0 references

volume

29

0 references

issue

1

0 references

page(s)

11-17

0 references

cites work

Risk factors for intraocular melanoma and occupational exposure

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Evidence-Based Estimates of Outcome in Patients Irradiated for Intraocular Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

The history and future of chemotherapy for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Adjuvant therapy of melanoma with interferon: lessons of the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Hypoxic microenvironment as a cradle for melanoma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway—A Report of the Tumour Angiogenesis Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Involvement of HIF-1 in invasion of Mum2B uveal melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Regulation of VEGF-A in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Autocrine vascular endothelial growth factor/vascular endothelial growth factor receptor-2 growth pathway represents a cyclooxygenase-2-independent target for the cyclooxygenase-2 inhibitor NS-398 in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Vascular endothelial growth factor a in eyes with uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

Biological evidence for dual antiangiogenic-antiaromatase activity of the VEGFR inhibitor PTK787/ZK222584 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9424-6

VEGF as a biomarker for metastatic uveal melanoma in humans

21 January 2018

1 reference

12 December 2020

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

1 reference

12 December 2020

Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.

1 reference

12 December 2020

Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1

1 reference

12 December 2020

Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

1 reference

12 December 2020

Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma

1 reference

12 December 2020

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

1 reference

12 December 2020